Skip to main content
. 2015 Feb 4;8:89–96. doi: 10.2147/DMSO.S78877

Table 9.

Compliance assessment (N=15/group)

Compliance Statins + Berberol® Ezetimibe + Berberol® Berberol®
Very poor 0 0 0
Poor 7 7 0
Fair 6 6 5
Good 2 2 10
Excellent 0 0 0

Note: N: number of individuals per group.